Search filters

List of works by Isabelle Ragueneau-Majlessi

A useful tool for drug interaction evaluation: The University of Washington Metabolism and Transport Drug Interaction Database

scientific article published on October 1, 2010

Application of receiver operating characteristic analysis to refine the prediction of potential digoxin drug interactions.

scientific article published on 25 April 2013

Breast cancer resistance protein (ABCG2) in clinical pharmacokinetics and drug interactions: practical recommendations for clinical victim and perpetrator drug-drug interaction study design.

scientific article

Carbamazepine pharmacokinetics are not affected by zonisamide: in vitro mechanistic study and in vivo clinical study in epileptic patients

scientific article published on November 2004

Developing User Personas to Aid in the Design of a User-Centered Natural Product-Drug Interaction Information Resource for Researchers.

scientific article published on 5 December 2018

Drug-Drug Interactions of Infectious Disease Treatments in Low-Income Countries: A Neglected Topic?

scientific article published on 21 March 2019

Identification and Evaluation of Clinical Substrates of Organic Anion Transporting Polypeptides 1B1 and 1B3

scientific article published on 12 March 2019

Importance of Multi-P450 Inhibition in Drug–Drug Interactions: Evaluation of Incidence, Inhibition Magnitude, and Prediction from in Vitro Data

scientific article published on September 27, 2012

In Vitro-to-In Vivo Extrapolation of Transporter Inhibition Data for Drugs Approved by the US Food and Drug Administration in 2018

scientific article published on 25 January 2020

Inhibitors of Organic Anion-Transporting Polypeptides 1B1 and 1B3: Clinical Relevance and Regulatory Perspective

scientific article published on 20 March 2020

Interaction between clopidogrel and proton pump inhibitors: hypothesis to explain multifactorial CYP2C19 inhibition

scientific article published in December 2009

Intestinal Drug Interactions Mediated by OATPs: A Systematic Review of Preclinical and Clinical Findings

scientific article

Investigating ABCB1-Mediated Drug-Drug Interactions: Considerations for In vitro and In vivo Assay Design.

scientific article

Key Findings from Preclinical and Clinical Drug Interaction Studies Presented in New Drug and Biological License Applications Approved by the Food and Drug Administration in 2014.

scientific article published on 30 September 2015

Lack of a clinically significant effect of zonisamide on phenytoin steady-state pharmacokinetics in patients with epilepsy

scientific article published in November 2004

Lack of clinically significant pharmacokinetic interactions between zonisamide and lamotrigine at steady state in patients with epilepsy

scientific article published in April 2005

Lack of pharmacokinetic interactions between steady-state zonisamide and valproic acid in patients with epilepsy

scientific article published in January 2005

Levetiracetam does not alter the pharmacokinetics of an oral contraceptive in healthy women

scientific article published in July 2002

Mechanisms and Clinical Significance of Pharmacokinetic-Based Drug-Drug Interactions with Drugs Approved by the U.S. Food and Drug Administration in 2017

scientific article published on 15 November 2018

New antiepileptic drugs: review on drug interactions

scientific article

Past, Present, and Future of Drug-Drug Interactions

scientific article published on 17 February 2019

Pharmacokinetics, safety, and tolerability of the new antiepileptic carisbamate in the elderly

scientific article

Physiologically Based Pharmacokinetic (Pbpk) Model of the Cyp2d6 Probe Atomoxetine: Extrapolation to Special Populations and Drug-Drug Interactions

scientific article published on 31 August 2017

Predicting substrates of the human breast cancer resistance protein using a support vector machine method

scientific article published on April 15, 2013

Quantitative correlations among CYP3A sensitive substrates and inhibitors: literature analysis

scientific article published in December 2007

Quantitative evaluation of pharmacokinetic inhibition of CYP3A substrates by ketoconazole: a simulation study

scientific article published in March 2009

Risk of Clinically Relevant Pharmacokinetic-Based Drug-Drug Interactions with Drugs Approved by the U.S. Food and Drug Administration Between 2013 and 2016.

scientific article published on 23 March 2018

Variability in In Vitro OATP1B1/1B3 Inhibition Data: Impact of Incubation Conditions on Variability and Subsequent Drug Interaction Predictions

scientific article published on 28 September 2019

What Can Be Learned from Recent New Drug Applications? A Systematic Review of Drug Interaction Data for Drugs Approved by the US FDA in 2015.

scientific article

e-PKGene: a knowledge-based research tool for analysing the impact of genetics on drug exposure

scientific article published on July 2011